THE PATHOLOGIC FEATURES OF RELAPSED BRAF-V600E LANGERHANS CELL HISTIOCYTOSIS WITH A CD163 PHENOTYPE

被引：0
|
作者：
Berklite, Lara [1 ]
Gifford, Andrew [2 ,3 ]
Lian, Derrick [4 ]
Lau, Loretta [3 ,5 ]
Nelson, Adam [5 ]
Lorsbach, Robert [1 ]
Roy, Somak [1 ]
Kumar, Ashish [6 ]
Picarsic, Jennifer [1 ]
机构：
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pediat Pathol, Coll Med, Cincinnati, OH USA
[2] Prince Wales Hosp, NSW Hlth Pathol, Anat Pathol, Randwick, NSW, Australia
[3] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[4] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore
[5] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia
[6] Univ Cincinnati, Canc & Blood Dis Inst, Cincinnati Childrens Hosp Med Ctr, Coll Med, Cincinnati, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor
    Mastropolo, Rosemarie
    Close, Allison
    Allen, Steven W.
    McClain, Kenneth L.
    Maurer, Scott
    Picarsic, Jennifer
    BLOOD ADVANCES, 2019, 3 (12) : 1848 - 1853
  • [42] Sustained Remission in a Patient with Malignant Histiocytosis using Targeted Therapy against BRAF-V600E Mutation
    Harmoney, Kathryn
    Modi, Arunkumar
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S75 - S75
  • [43] BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival
    Bhatia, Prateek
    Singh, Minu
    Sharma, Madhulika
    Sharma, Ajay
    Kakkar, Nandita
    Radhika, S.
    Trehan, Amita
    Bansal, Deepak
    BLOOD CELLS MOLECULES AND DISEASES, 2020, 82
  • [44] LANGERHANS CELL HISTIOCYTOSIS (LCH) BRAF V600E+COMBINED WITH OTHER LYMPHOPROLIFERATIVE DISORDERS: AN INTRIGUING CASE
    Stocchi, Francesca
    Santopietro, Michelina
    Mauro, Francesca Romana
    Palumbo, Giovanna
    Di Pippo, Tiziana
    Rizzo, Lorenzo
    Giona, Fiorina
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S31 - S32
  • [45] BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis
    Ozer, Erdener
    Sevinc, Akin
    Ince, Dilek
    Yuzuguldu, Resmiye
    Olgun, Nur
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2019, 22 (05) : 449 - 455
  • [46] ATYPICAL CT FINDINGS IN A PATIENT WITH A BRAF V600E MUTATED PULMONARY LANGERHANS CELL HISTIOCYTOSIS (PLCH)
    Willenbacher, Ella
    Willenbacher, Wolfgang
    Manzl, Claudia
    Brunner, Andrea
    Frank, Renate
    Loeffler-Ragg, Judith
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1003 - S1004
  • [47] High Prevalence of BRAF V600E Mutations in Langerhans Cell Histiocytosis of Head and Neck in Chinese Patients
    Liu, Xiaoxiao
    Zhang, Ye
    Zhou, Chuan-Xiang
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (08) : 836 - 843
  • [48] Adult-onset BRAF V600E-related multisystem Langerhans cell histiocytosis treated with vemurafenib
    Encarnacion-Mangubat, Lisa Denise A.
    Encarnacion, Lonabel A.
    JEADV CLINICAL PRACTICE, 2024, 3 (04): : 1219 - 1222
  • [49] Langerhans cell histiocytosis of bone with BRAF V600E mutation: a case report and the review of published work
    Terzi, N. Kaya
    Yilmaz, I.
    VIRCHOWS ARCHIV, 2019, 475 : S414 - S414
  • [50] Cyclin D1 and BRAF V600E immunohistochemical staining in pulmonary Langerhans cell histiocytosis
    Pors, Jennifer
    Churg, Andrew
    HISTOPATHOLOGY, 2020, 76 (07) : 1091 - 1093
12345